Skip to main content
Displaying 381 - 390 of 3943
# Title Department Research Year
381 Design, synthesis, and biological evaluation of new pyrimidine-5-carbonitrile derivatives bearing 1,3-thiazole moiety as novel anti-inflammatory EGFR inhibitors with cardiac safety profile Department of Pharmaceutical Organic Chemistry 2021
382 Design, synthesis, and biological evaluation of novel EGFR inhibitors containing 5-chloro-3-hydroxymethyl-indole-2-carboxamide scaffold with apoptotic antiproliferative activity Department of Pharmaceutical Organic Chemistry 2021
383 Design, synthesis, biological assessment and in silico ADME prediction of new 2-(4- (methylsulfonyl) phenyl) benzimidazoles as selective cyclooxygenase-2 inhibitors 2021
384 Design, Synthesis, Biological Evaluation, and Computational Studies of Novel Tri-Aryl Imidazole-Benzene Sulfonamide Hybrids as Promising Selective Carbonic Anhydrase IX and XII Inhibitors Department of Pharmaceutical Organic Chemistry 2021
385 Development and Evaluation of Letrozole‑Loaded Hyaluronic Acid/Chitosan‑Coated Poly(d,l‑lactide‑co‑glycolide) Nanoparticles Department of Pharmaceutics 2021
386 Development and Evaluation of Letrozole‑Loaded Hyaluronic Acid/Chitosan‑Coated Poly(d,l‑lactide‑co‑glycolide) Nanoparticles Department of Pharmaceutics 2021
387 Development and Evaluation of Letrozole‑Loaded Hyaluronic Acid/Chitosan‑Coated Poly(d,l‑lactide‑co‑glycolide) Nanoparticles Department of Pharmaceutics 2021
388 Development of new hetero‑steroid hybrids with antiproliferative activity against MCF‑7 breast cancer cells Department of Pharmaceutical Organic Chemistry 2021
389 Different cellulosic polymers for synthesizing silver nanoparticles with antioxidant and antibacterial activities Department of Industrial Pharmacy 2021
390 Discovery of Novel Oxazole-Based Macrocycles as Anti-Coronaviral Agents Targeting SARS CoV-2 Main Protease 2021